Brookfield Corp’s Steris STE Stock Holding History

Brookfield Corp’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20,264	Closed	-$3.74M	–	772
2022 Q4	$3.74M	Buy	+20,264	New	+$3.56M	0.01%	311
2022 Q3	–	Sell	-18,883	Closed	-$3.89M	–	763
2022 Q2	$3.89M	Buy	+18,883	New	+$4.26M	0.02%	301

Other funds holding STE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brookfield Corp's STE Position: Q1 2023 in Review

Brookfield Corp sold out of Steris (STE) in Q1 2023, closing a stake of 20,264 shares — an estimated $3.74M sold.

Brookfield Corp first reported a position in STE in Q2 2022 and held it in 2 quarters. The position peaked at $3.89M in Q2 2022. 620 funds tracked by Wall St. Rank hold STE as of Q1 2023.

Brookfield Corp reported no remaining Steris position as of Q1 2023 after selling out during the quarter.
Brookfield Corp sold 20,264 Steris shares in Q1 2023, an estimated $3.74M.
Brookfield Corp first reported a position in Steris in Q2 2022 and held it in 2 quarters.
Brookfield Corp's Steris position peaked at $3.89M in Q2 2022.
620 funds tracked by Wall St. Rank held Steris as of Q1 2023.

Based on Brookfield Corp's 13F filing for Q1 2023, filed 15 May 2023.